Clovis Oncology
CLVS
#10870
Rank
NZ$21.51 M
Marketcap
NZ$0.15
Share price
0.00%
Change (1 day)
-94.95%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -NZ$0.35 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2021 the company made an earning of -NZ$0.43 Billion, an increase over its 2020 earnings that were of -NZ$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$0.35 Billion-20.2%
2021 -NZ$0.43 Billion-32.64%
2020 -NZ$0.64 Billion-9.06%
2019 -NZ$0.7 Billion7.49%
2018 -NZ$0.65 Billion4.42%
2017 -NZ$0.63 Billion-8.83%
2016 -NZ$0.69 Billion-0.4%
2015 -NZ$0.69 Billion140.82%
2014 -NZ$0.29 Billion86.64%
2013 -NZ$0.16 Billion19.53%
2012 -NZ$0.13 Billion
2010 -NZ$48.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-8,711.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.73 B-3,305.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$23.42 B-5,994.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.55 B-16,092.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$27.58 B-7,040.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
NZ$79.81 M-120.08%๐Ÿ‡บ๐Ÿ‡ธ USA